The study of E-selectin and its inhibitors in pediatric AML has been minimal; however, a recent report demonstrated that E-selectin ligand expression is also associated with poor survival in a small cohort of AML patients treated on COG AAML1031 [39]. The gene discussed is SELE; the disease is acute myeloid leukemia.